At the 2015 annual EHA meeting in Vienna, one session was dedicated to the ‘treatment and outcome in non-Hodgkin lymphoma’. Topics included, among others, the long-term outcome in early stage extra-nodal marginal zone lymphoma, a subgroup analysis of the MCL-002 (SPRINT) study, the PINK/PINK-E prognostic model for extra nodal NK/T-cell lymphoma.

(BELG J HEMATOL 2015;6(3):101–3)